Novo Nordisk Delivers Strong Financial Results Amid Rising Competition
Novo Nordisk just posted another set of strong numbers. The Danish drugmaker behind Ozempic and Wegovy reported a sharp rise in profit and sales, even as new rivals enter the weight-loss drug market. We’re talking about a 32% jump in quarterly net profit to DKK 26.5 billion ($3.85 billion) and continued demand for its blockbuster…